Is Curis, Inc. (CRIS) Stock About to Get Hot Thursday?

Overall market sentiment has been down on Curis, Inc. (CRIS) stock lately. CRIS receives a Bearish rating from InvestorsObserver Stock Sentiment Indicator.

Curis, Inc. has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on CRIS!

See Full CRIS Report

What is Stock Sentiment?

Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score. As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend. Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor. InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon. The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.

What's Happening With CRIS Stock Today?

Curis, Inc. (CRIS) stock is trading at $0.55 as of 1:59 PM on Thursday, Dec 29, an increase of $0.05, or 10.44% from the previous closing price of $0.49. The stock has traded between $0.49 and $0.55 so far today. Volume today is 807,555 compared to average volume of 1,046,991. To screen for more stocks like Curis, Inc. click here.

More About Curis, Inc.

Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge. Click Here to get the full Stock Report for Curis, Inc. stock.